Anthem Biosciences Ltd Share Price

Q: What is the share price of Anthem Biosciences Ltd today?

Anthem Biosciences Ltd share price as on 18 Nov 2025 is ₹661.9

Pharmaceuticals

NSE: ANTHEM Mid Cap ISIN: INE0CZ201020

As on 19 November 2025 at 01:29 IST

₹661.90

-3.55

(-0.53%)

Sell Buy

Over 1 Month

-12.16%

Over 6 Months

-8.89%

Over 1 Year

None%

Over 3 Years

None%

Anthem Biosciences Ltd Summary

Close ₹665.45

Open ₹681

High ₹682.70

Low ₹664.05

Volume 3,12,967

Net Turnover (in Cr) ₹21.01

52Wk High ₹873.50

52Wk Low ₹664.05

52Wk High / Low

664.05

873.50

Anthem Biosciences Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹37,372.34

EPS (TTM) 10.64

Book Value (BV) 50.81

Div. Yield -

P/E (TTM) 62.54

Price/Book Value 13.10

Delivery % 55.14 %

Face Value 2

Key Ratios

PE Ratio -

PB Ratio -

EV to Sales -

PEG Ratio -

ROA 19.41

ROE 22.98

Debt-Equity 0.06

Net Profit Margin 27.50

Operating Profit Margin 43.39

Anthem Biosciences Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,930.29	1,483.07	1,133.99	1,280.24	1,140.45
Total Expenses	1,273.42	1,005.75	698.50	734.10	774.88
Profit Before Tax	656.87	477.32	497.30	546.14	365.57
Profit After Tax	451.26	367.31	385.19	405.54	271.29
Operating Profit After Depreciation	667.20	486.85	442.26	556.23	382.53

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	705.10	482.52	448.89	329.01	361.41
Total Non Current Assets	1,070.87	916.56	691.29	521.15	418.02
Total Current Assets	1,736.72	1,481.56	1,323.17	1,097.71	615.80
Total Assets	2,807.58	2,398.11	2,014.46	1,618.87	1,033.83
Total Shareholder's Fund	2,409.86	1,924.65	1,740.67	1,355	701.46

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	418.34	140.15	305.99	332.91	277.64
Net Cash Used In Investing Activities	-152.11	-221.46	-376.02	-205.45	-196.03
Net Cash Used In Financing Activities	-133.60	-77.18	63.97	180.68	-63.27

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,950.09	1,488.06	1,134.30	1,280.24	1,140.45
Total Expenses	1,238.67	1,003.29	698.32	733.64	774.87
Profit Before Tax	711.42	484.77	497.78	546.59	365.58
Profit After Tax	506.19	374.78	385.67	405.99	271.31
Operating Profit After Depreciation	720.51	493.92	442.73	556.68	382.55

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	624.06	477.69	448.89	329.01	361.41
Total Non Current Assets	1,171.49	878.74	673.39	522.10	417.93
Total Current Assets	1,664.07	1,445.49	1,319.62	1,097.08	615.81
Total Assets	2,835.56	2,324.23	1,993.02	1,619.18	1,033.73
Total Shareholder's Fund	2,473.21	1,933.07	1,741.62	1,355.46	701.47

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	439.84	164.41	318.98	333.35	277.55
Net Cash Used In Investing Activities	-246.31	-191.76	-377.91	-205.78	-196.09
Net Cash Used In Financing Activities	-66.42	-131.59	52.85	180.68	-63.27

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	550.03	540.21	483.20	-	524.96
Total Expenses	332.12	348.71	288.01	-	329.73
Profit Before Tax	229.61	186.25	178.31	-	199.54
Profit After Tax	173.43	135.79	82.62	124.33	161.93
Operating Profit after Depreciation	266.14	214.31	209.25	-	223.08

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	552.23	538.01	478.98	-	524.86
Total Expenses	326.57	342.58	280.87	-	324.05
Profit Before Tax	253.31	198.94	212.84	-	206.97
Profit After Tax	198.43	148.34	122.56	127.99	170.30
Operating Profit after Depreciation	279.46	223.16	235.93	-	228.64

Anthem Biosciences Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 658.77

S2 652.08

S3 640.12

Pivot 670.73

R1 677.42

R2 689.38

R3 696.07

Moving Average

20 SMA 708.86

50 SMA 766

100 SMA -

200 SMA -

Anthem Biosciences Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,763.70	₹4,23,170.71
Divis Laboratories Ltd	₹6,523.25	₹1,73,171.79
Torrent Pharmaceuticals Ltd	₹3,816.75	₹1,29,170.36
Cipla Ltd	₹1,536.25	₹1,24,093.85
Dr Reddys Laboratories Ltd	₹1,244.50	₹1,03,868.61

Anthem Biosciences Ltd Top Mutal Funds Invested

Fund Name	AUM
Quant Momentum Fund	6.45%
HDFC Business Cycle Fund	3.19%
SBI Healthcare Opportunities Fund	2.09%
SBI MNC Fund	1.91%
Quant Mid Cap Fund	1.40%

Anthem Biosciences Ltd News

Anthem Biosciences to announce Quarterly Result

On 8 November 2025

24 Oct 2025, 09:56 am

Anthem Biosciences to declare Quarterly Results

On 13 August 2025

11 Aug 2025, 11:20 am

Anthem Biosciences jumps on debut

Shares of Anthem Biosciences were currently trading at Rs 726.35 at 10:21 IST on the BSE, representing a premium of 27.43% compared with the issue price of Rs 570.

21 Jul 2025, 10:26 am

Anthem Biosciences Ltd Stock Analysis

Annual revenue for Anthem Biosciences Ltd increased by 31.05% to ₹1,950.09 crore in FY 2025 from ₹1,488.06 crore in FY 2024.
Annual Net Profit for Anthem Biosciences Ltd increased by 35.06% to ₹506.19 crore in FY 2025 from ₹374.78 crore in FY 2024.
Promoter Shareholding in Anthem Biosciences Ltd decreased by 2.85% in the most recent quarter, from 76.88% in July 2025 to 74.69% in September 2025.
Anthem Biosciences Ltd delivered a 1-year return of 0% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Anthem Biosciences Ltd share price moved down by 0.53% from its previous close of INR ₹665.45. The latest Anthem Biosciences Ltd share price is INR ₹661.90.
Anthem Biosciences Ltd share price today has been at a low of 656.60 and a high of 670. Over the past 52 weeks, the Anthem Biosciences Ltd share price has seen a low of 656.60 and a high of 873.50.